(Q43986704)

English

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Semliki Forest virus

0 references

experimental autoimmune encephalomyelitis

0 references

Brian J. Sheahan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Alan Jerusalmi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Margaret M Morris-Downes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gregory J Atkins

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

886-894

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14664790%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Semliki Forest virus vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: relevance for human disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Cell death mechanisms in the olfactory bulb of rats infected intranasally with Semliki forest virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Manipulation of the Semliki Forest virus genome and its potential for vaccine construction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in ABH and SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Effect of viral infection on experimental allergic encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Gene transfer into hippocampal slice cultures with an adenovirus vector driven by cytomegalovirus promoter: stable co-expression of green fluorescent protein and lacZ genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Modified herpes simplex virus delivery of enhanced GFP into the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Regulated transgene delivery by ganciclovir in the brain without physiological alterations by a live attenuated herpes simplex virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Adeno-associated virus vectors: activity and applications in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Differences in the cellular distributions of two microtubule-associated proteins, MAP1 and MAP2, in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG(35-55)peptide in C57BL6/J strain of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43986704&oldid=2105327790"